1. Home
  2. CCTG vs GRI Comparison

CCTG vs GRI Comparison

Compare CCTG & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CCSC Technology International Holdings Limited

CCTG

CCSC Technology International Holdings Limited

HOLD

Current Price

$0.47

Market Cap

1.8M

Sector

N/A

ML Signal

HOLD

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$2.63

Market Cap

1.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCTG
GRI
Founded
1993
2018
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
1.9M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
CCTG
GRI
Price
$0.47
$2.63
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$160.00
AVG Volume (30 Days)
36.1K
39.2K
Earning Date
12-23-2025
01-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.08
$0.18
52 Week High
$2.61
$11.12

Technical Indicators

Market Signals
Indicator
CCTG
GRI
Relative Strength Index (RSI) 46.06 53.10
Support Level $0.45 $2.18
Resistance Level $1.13 $2.73
Average True Range (ATR) 0.05 0.23
MACD -0.01 -0.04
Stochastic Oscillator 42.33 47.44

Price Performance

Historical Comparison
CCTG
GRI

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

Share on Social Networks: